Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Subviral Agents01:29

Subviral Agents

580
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
580
Air-entraining Agents01:27

Air-entraining Agents

276
Air-entraining agents improve the durability and workability of concrete in climates with frequent freezing and thawing. These agents prevent cracks by introducing small air bubbles into the mix, creating spaces accommodating water expansion when temperatures drop. The air-entraining agents lower the surface tension of water, forming stable, small air bubbles. This method is more effective than having accidental large voids, as the intentional, smaller, and evenly distributed air voids improve...
276
Masking and Demasking Agents01:19

Masking and Demasking Agents

3.6K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
3.6K
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

1.3K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.3K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

681
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
681
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

1.7K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating Extracellular Vesicle Protein Biomarkers for the Early Detection of High-Grade Serous Ovarian Cancer.

Molecular & cellular proteomics : MCP·2026
Same author

Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles.

Cancer research communications·2025
Same author

Spatial transcriptomic profiling of the human fallopian tube epithelium reveals region-specific gene expression patterns.

Communications biology·2025
Same author

LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarker.

NPJ precision oncology·2025
Same author

Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells.

Nature biotechnology·2024
Same author

Tracking Small Extracellular Vesicles Using a Minimally Invasive PicoGreen Labeling Strategy.

ACS applied bio materials·2024

Related Experiment Video

Updated: Feb 8, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

ZnO Nanoparticles: A Promising Anticancer Agent.

Gunjan Bisht1, Sagar Rayamajhi2

  • 1Department of Chemical Science and Engineering, Kathmandu University Dhulikhel, Nepal.

Nanobiomedicine
|June 27, 2018
PubMed
Summary
This summary is machine-generated.

Zinc oxide nanoparticles show promise as a targeted cancer therapy. Their unique properties allow selective targeting of cancer cells, potentially offering a more effective alternative to traditional treatments.

Keywords:
Anti-cancer AgentCytotoxicityEnhanced Permeation and Retention Effect (EPR)Reactive Oxygen Species (ROS)SelectivityZinc Oxide (Zno)Zinc-mediated Protein Activity Disequilibrium

More Related Videos

Methods for Rearing the Parasitoid Ganaspis brasiliensis, a Promising Biological Control Agent for the Invasive Drosophila suzukii
07:56

Methods for Rearing the Parasitoid Ganaspis brasiliensis, a Promising Biological Control Agent for the Invasive Drosophila suzukii

Published on: June 2, 2022

4.9K
Author Spotlight: Design and Evaluation of Au-Electroplated Carbon Fiber Cloth Electrodes for Hydrogen Peroxide Fuel Cells
06:39

Author Spotlight: Design and Evaluation of Au-Electroplated Carbon Fiber Cloth Electrodes for Hydrogen Peroxide Fuel Cells

Published on: October 20, 2023

3.9K

Related Experiment Videos

Last Updated: Feb 8, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Methods for Rearing the Parasitoid Ganaspis brasiliensis, a Promising Biological Control Agent for the Invasive Drosophila suzukii
07:56

Methods for Rearing the Parasitoid Ganaspis brasiliensis, a Promising Biological Control Agent for the Invasive Drosophila suzukii

Published on: June 2, 2022

4.9K
Author Spotlight: Design and Evaluation of Au-Electroplated Carbon Fiber Cloth Electrodes for Hydrogen Peroxide Fuel Cells
06:39

Author Spotlight: Design and Evaluation of Au-Electroplated Carbon Fiber Cloth Electrodes for Hydrogen Peroxide Fuel Cells

Published on: October 20, 2023

3.9K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Nanoparticles are increasingly vital in cancer therapy due to their targeted delivery and efficacy.
  • Zinc oxide (ZnO) nanoparticles possess advantageous properties like biocompatibility, selectivity, and ease of synthesis for anticancer applications.
  • Zinc is essential for cellular processes; altered zinc levels in cancer cells can be detrimental, with low levels promoting cancer and high levels inducing toxicity.

Purpose of the Study:

  • To evaluate the potential of ZnO nanoparticles as a targeted anticancer agent.
  • To explore the mechanisms behind the selective cytotoxicity of ZnO nanoparticles towards cancer cells.

Main Methods:

  • Review of existing research on nanoparticle-based cancer therapy.
  • Analysis of ZnO nanoparticle properties, including biocompatibility, selectivity, and synthesis.
  • Investigation of zinc's role in cellular processes and cancer progression.
  • Examination of mechanisms like the enhanced permeability and retention (EPR) effect and reactive oxygen species (ROS) generation.

Main Results:

  • ZnO nanoparticles exhibit biocompatibility, high selectivity, and enhanced cytotoxicity.
  • Altered zinc levels significantly impact cancer initiation and progression.
  • High zinc concentrations and ZnO nanoparticles induce toxicity in cancer cells, potentially via ROS and protein activity disruption.
  • ZnO nanoparticles demonstrate selective localization in cancer cells through EPR effect and electrostatic interactions.

Conclusions:

  • ZnO nanoparticles show significant promise as a targeted anticancer agent due to their selective action.
  • Their ability to selectively target and induce cytotoxicity in cancer cells, mediated by ROS, positions them as a potential advancement over traditional therapies.